are we closer to personalized medicine in ms?
DESCRIPTION
Are We Closer to Personalized Medicine in MS?. Disclaimers. Program Goals. What Is Personalized Medicine?. What Is Personalized Medicine? (cont). Prognostic Indicators. Biomarkers: JC Virus Antibody Index. Biomarkers. Patient Factors. Drug Factors. Assessing Risk. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/1.jpg)
Are We Closer to Personalized Medicine in MS?
![Page 2: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/2.jpg)
![Page 3: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/3.jpg)
Disclaimers
![Page 4: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/4.jpg)
Program Goals
![Page 5: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/5.jpg)
What Is Personalized Medicine?
![Page 6: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/6.jpg)
What Is Personalized Medicine? (cont)
![Page 7: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/7.jpg)
Prognostic Indicators
![Page 8: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/8.jpg)
Biomarkers: JC Virus Antibody Index
![Page 9: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/9.jpg)
Biomarkers
![Page 10: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/10.jpg)
Patient Factors
![Page 11: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/11.jpg)
Drug Factors
![Page 12: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/12.jpg)
Assessing Risk
![Page 13: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/13.jpg)
Experience With MS Drugs: Clinical Practice vs Clinical Trials
![Page 14: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/14.jpg)
Monitoring Response
![Page 15: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/15.jpg)
Monitoring Response: Modified Rio Score
![Page 16: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/16.jpg)
Monitoring Response (cont)
![Page 17: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/17.jpg)
Switching and Sequencing Therapy
![Page 18: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/18.jpg)
Risk Stratification at Diagnosis -- and Beyond
![Page 19: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/19.jpg)
On the Horizon: Agents in Development
![Page 20: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/20.jpg)
On the Horizon: Reduced Injections
![Page 21: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/21.jpg)
Summary and Key Points
![Page 22: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/22.jpg)
Abbreviations
![Page 23: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/23.jpg)
References
![Page 24: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/24.jpg)
References (cont)
![Page 25: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/25.jpg)
References (cont)
![Page 26: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/26.jpg)
References (cont)
![Page 27: Are We Closer to Personalized Medicine in MS?](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815ef0550346895dcdb047/html5/thumbnails/27.jpg)
References (cont)